Clinical Trials Logo

Clinical Trial Summary

The overall goal of this study is to evaluate the association between sodium and TH17 cells in human subjects. The subjects will have levels of TH-17 and various hormones measured on low salt diet, low salt diet with intravenous normal saline, and high salt diet.


Clinical Trial Description

In recent years, dietary sodium intake has dramatically increased and has been shown to play an active role in a number of detrimental diseases including hypertension and cardiovascular complications. Additionally, in the developed world, there has been a steady increase in autoimmune diseases. Type 17 helper T cells (Th17) have been shown to play an active role in the development of autoimmune diseases. Serum glucocorticoid kinase (SGK1) has been shown to influence sodium transport and salt homeostasis in many cell types (Wulf, J. Clin. Invest. 2002; Salker, Nature Med 2011). Prior in vitro and in vivo studies have shown that an increase in salt concentration in the media or dietary salt intake in mice induces SGK1 expression and enhances TH17 cell differentiation and worsens experimental autoimmune encephalomyelitis (EAE), animal model for multiple sclerosis (Kleinewietfeld, Nature 2013; Wu, Nature 2013). The findings in this study can substantially increase the investigators understanding of environmental factors that modulate the development of autoimmunity in humans. In animal models the worsening effects of a high salt diet on EAE are dramatic. To the investigators knowledge, the proposed study will be the first to determine if salt intake has the same adverse impact in humans. If documented, one could envision the development of a novel treatment approach for human autoimmunity via the regulation of salt intake. Thus, the overall goal of this study is to evaluate the association between sodium and TH17 cells in human subjects. In addition to measuring TH17 cells by flow cytometry the investigators will also measure interleukins such as IL-17a, IL-17f, IL-23 that are important in TH17 differentiation and production. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02261688
Study type Interventional
Source Brigham and Women's Hospital
Contact
Status Terminated
Phase N/A
Start date March 2014
Completion date August 2019

See also
  Status Clinical Trial Phase
Completed NCT02421276 - Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome N/A
Recruiting NCT03370861 - How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Recruiting NCT06363903 - ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation
Recruiting NCT04791150 - Rheumatologic Adverse Events and Cancer Immunotherapy N/A
Recruiting NCT05894746 - Gfree - For Improved Blood Sugar and Reduced Inflammation. N/A
Completed NCT02715323 - Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Recruiting NCT05928585 - A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers Phase 1
Completed NCT03767712 - Trauma as a Trigger for Autoimmunity
Recruiting NCT03206099 - NIAID Centralized Sequencing Protocol
Completed NCT00649246 - Prospective Assessment in Newborns for Diabetes Autoimmunity
Recruiting NCT04521790 - Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Terminated NCT01129232 - Diabetes Virus Detection Project, Intervention With GAD-alum Phase 2
Recruiting NCT04119713 - Autoimmunity After Checkpoint Blockade
Not yet recruiting NCT02912442 - Thyroid Autoimmunity and Reproductive Failure in Danish Women N/A
Terminated NCT04859829 - Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment